Results 141 to 150 of about 4,998,430 (314)

Acute retinal necrosis presenting exudative retinal detachment: a case report

open access: yesFrontiers in Medicine
BackgroundAcute retinal necrosis (ARN) is a severe, rapidly progressive viral retinitis that is commonly complicated by rhegmatogenous retinal detachment in its late stage.
Han Wang   +3 more
doaj   +1 more source

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Ocular surface changes in mice with streptozotocin-induced diabetes and diabetic polyneuropathy

open access: yes
4355Purpose: Diabetes mellitus (DM) is a leading risk factor for corneal neuropathy and dry eye disease (DED). Another common consequence of DM is diabetic peripheral polyneuropathy (DPN).
Grus, Franz Hermann   +11 more
core   +1 more source

A study exploring the causal relationship between glaucoma and anxiety disorders

open access: yesFrontiers in Medicine
BackgroundGlaucoma, a leading cause of global blindness, is characterized by optic nerve damage and visual field loss. Previous studies have suggested a potential association between glaucoma and anxiety disorders.
Bin Lin   +23 more
doaj   +1 more source

Efficacy of Fampridine on Refractory Optic Neuritis in Neuromyelitis Optica Spectrum Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorders (NMOSD) usually occur with acute refractory optic neuritis (ON). However, there is a lack of efficacious treatments to improve recovery. Since fampridine has been found to improve the prognosis of multiple sclerosis (MS) and MS‐related ON, it is necessary to explore the efficacy of fampridine ...
Hongxuan Wang   +9 more
wiley   +1 more source

Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations

open access: yes, 2018
Jennifer S Harthan,1 Ellen Shorter2 1Illinois College of Optometry, Chicago, IL, USA; 2University of Illinois at Chicago, Chicago, IL, USA Abstract: Scleral lenses are being prescribed for the management of corneal irregularity, uncomplicated refractive ...
Shorter E, Harthan JS
core  

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)

open access: yesArthritis Care &Research, EarlyView.
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram   +25 more
wiley   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho   +4 more
wiley   +1 more source

Ocular surface leproma

open access: yesJournal of Postgraduate Medicine, 2018
Ram, J, Kakkar, N, Gupta, G, Gupta, PC
openaire   +2 more sources

Ocular surface temperature

open access: yes, 1989
A wide-field color-coded infra-red imaging device was applied to the measurement of i) the temperature profile across the ocular surface and ii) the temporal stability of central corneal temperature, on 21 subjects.
Efron, Nathan   +2 more
core  

Home - About - Disclaimer - Privacy